Menu

Victoria Aranda is a Team Manager and Senior editor with Nature, where she handles research manuscripts on Clinical and Translational Medicine. She works in close relationship with the research community to ensure Nature continues to publish cutting-edge, high-quality clinical science and technology. She leads cross-journal projects with editors at other journals, and contributes to the development and innovation of editorial policies to best serve community stakeholders, including researchers, practitioners and patients. Victoria received her PhD from the University of Navarra in Spain, where she studied how alterations in epithelial polarity and tissue architecture contribute to liver disease.

Dr. Sandra Capellera Garcia is a biomedical researcher specializing in scientific writing and communication, with extensive experience in academic and non-profit research environments across the United States and Europe. She currently works at St. Jude’s Children’s Research Hospital, where she helps investigators in the Department of Hematology craft high-quality scientific documents and leads scientific communication workshops for trainees. She obtained her PhD in Biomedicine and Stem Cell Biology at Lund University, Sweden.

Ana Céspedes is a globally recognized leader in the health space, with nearly three decades of experience driving innovation, strategy, access and impact across the business consulting, pharmaceutical, biotechnology, and global health sectors. As Chief Executive Officer of Vitamin Angels, Ana is dedicated to advancing its mission of improving maternal and child nutrition worldwide. Ana holds a Doctorate in Pharmacy from the University Complutense of Madrid and advanced degrees and certifications from the London School of Economics, IESE, MIT, and GAP International. She is a founding member of Spanish Women Leaders in Life Sciences, a global network of female leaders committed to shaping the future of health sciences.

Juana Fernandez Silva is a seasoned global executive with over 25 years of experience in technology, focusing on strategic alliances, cloud computing, advanced data analytics, and Artificial Intelligence. Since joining Microsoft in 2010, she has spearheaded the development of business initiatives involving cutting-edge cloud solutions. Currently, she serves as the Global Director for Cloud and AI Platform solutions, based in New York City. Recognized among Spain’s Top 100 Women Leaders in 2023, Juana is also dedicated to mentoring emerging leaders in STEM. She holds an MSc in Telecommunications Engineering, an Executive MBA, and a PDD from IESE.

Yaihara Fortis Santiago holds a bachelor’s degree in Biology from the University of Puerto Rico at Río Piedras and a PhD in Neuroscience from Brandeis University. Upon graduating with her PhD, she joined the National Science Foundation as an AAAS Science and Technology Policy Fellow. In 2014, she joined The New York Academy of Sciences, where she created the first leadership program for STEM graduate students. In 2017, she joined Memorial Sloan Kettering Cancer Center (MSK) to lead the postdoctoral office. In 2025, she expanded her portfolio to oversee MSK’s scientific Pipeline Training Programs.

Carolina Ibañez is currently the Associate Vice President of Equity Research and Biotechnology at Stifel Financial, an investment and financial services bank. Prior to her involvement in biotechnology, Carolina was the Equity Research Associate in Life Sciences and Diagnostics at Stifel, Citi, and Janney Montgomery Scott. Carolina completed an MBA at Rutgers University, a PhD in Molecular Biology and Genetics from the University of Glasgow, and a degree in biology from the Autonomous University of Barcelona. In the last year of her degree, Carolina won an Erasmus Scholarship from the University of Aberdeen in Scotland.

Neus Rafel is an Associate Medical Lead at Coefficient Health, an independent healthcare marketing and medical communications agency based in New York City. She holds a PhD in Genetics from the University of Barcelona and completed her postdoctoral research at Columbia University. Neus began her career in medical communications as a medical writer and has since contributed to the launch of multiple innovative therapies, particularly in the rare disease space. Her work sits at the intersection of science, strategy, and storytelling—translating complex data into meaningful, impactful communications.